Mathew Hawkins

Mathew Hawkins serves as Chief Technology Officer at CaryRx. CaryRx operates in the information technology & services sector with approximately 42.0 employees.

Industry & Role Insights

• • MessageCEO tracks 50,503 executives in the information technology & services sector.
• • Our database includes 201,469 c suite-level executives.

Rackspace MailGun Gmail Google Apps Amazon AWS Workable Google Tag Manager Mixpanel Google Play Google Font API reCAPTCHA Mobile Friendly

pharmacy delivery logistics software patient experience technology information & internet ai-driven healthcare prescription fulfillment automated clinical interventions digital therapeutics healthcare technology caryconnect caryrx onedash clair clinical decision support pharmaceutical manufacturers health plans telehealth services drug interactions clinical guidelines hedis measures star ratings adherence programs data analytics patient engagement real-time insights medication management automated workflows benefits investigation care gap closure population management digital health solutions evidence-based clinical tools home delivery pharmacy nationwide access patient retention rx fulfillment services telehealth integration clinical workflow automation medication reminders refill management customizable api direct-to-consumer distribution clinical references evidence-based medicine patient-centered care healthcare professionals clinical sequencing funnels sales rep tools medical support real-time patient data digital pharmacy solutions patient-centric technology information technology & services

MJ

Marvin Jo CTO at 위블링

RK

Robert Kim CEO, North America at 당근마켓

KL

Kyung Lim CTO at 인터파크

AR

Alex Ryu Chief Operating Officer, Supply Chain Solutions Group at 동양시스템즈(주)

WK

Wonho Kang 라포테이블(팔도감) | CEO · Product Lead at 라포랩스(퀸잇)

Outreach Guidance — information technology & services Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Mathew Hawkins, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Mathew Hawkins's Position in the MessageCEO Database

• •Mathew Hawkins is 1 of 1 verified executive contact we track at CaryRx.
• •49,754 verified executive contacts in information technology & services are in the MessageCEO database.
• •522 verified contacts work at information technology & services companies in the 42.0 employee range (same size as CaryRx).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Mathew Hawkins directly?

Mathew Hawkins's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at CaryRx. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mathew Hawkins work for?

Mathew Hawkins is Chief Technology Officer at CaryRx, a company in the information technology & services sector with 42.0 employees.

Can I pitch or sell to Mathew Hawkins?

As Chief Technology Officer at CaryRx, Mathew Hawkins is a key decision-maker in the information technology & services sector. MessageCEO Pro gives you verified email to reach Mathew Hawkins directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mathew Hawkins in?

Mathew Hawkins works in the information technology & services industry as Chief Technology Officer at CaryRx. MessageCEO provides verified contact information for executives across all major industries.

Is Mathew Hawkins's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mathew Hawkins's profile is kept up-to-date with the latest available information.

Last updated: July 24, 2026